Search

Author/Creator Gutierrez, M

1. 414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors. (23rd October 2018)

Authors:
Cho, B C; Perets, R; Bar, J; Ahn, M-J; Kim, D-W; Yoh, K; Nagrial, A; Spigel, D R; Lee, D H; Gutierrez, M; Kotasek, D; Siddiqi, S; Chain, A; Butts, B D; Zhang, Y; Li, X; Cyrus, J; Tse, A; Altura, R A; Rasco, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 98P Results from a phase I study of MK-1308 (anti–CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancer. (15th December 2019)

Authors:
Cho, B C; Yoh, K; Bar, J; Nagrial, A; Spigel, D R; Gutierrez, M; Kim, D-W; Kotasek, D; Rasco, D; Niu, J; Satouchi, M; Ahn, M-J; Lee, D H; Maurice-Dror, C; Siddiqi, S; Li, X; Cyrus, J; Altura, R A; Perets, R
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. AB0059 Synovial secretion of pro-inflammatory and pro-oxidant molecules triggered by monosodium urate crystals induces ngf and h2o2 pain mediators in the chondrocyte. (15th June 2017)

Authors:
Lopez-Reyes, AG; Medina-Luna, D; Satamaria-Olmedo, M; Martinez-Flores, K; Zamudio-Cuevas, Y; Fernandez-Torres, J; Martinez-Nava, G; Clavijo-Cornejo, D; Olivos-Meza, A; Gutierrez, M; Fernandez-Moreno, M; Blanco, F; Pineda, C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1067
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Administration of a human recombinant apyrase (AZD3366) limits myocardial tissue injury and improves cardiac function in a pig model of STEMI assessed by serial CMR. (3rd October 2022)

Authors:
Vilahur, G; Radike, M; Sutelman, P; Ben-Aicha, S; Gutierrez, M; Casani, L; Mendieta, G; Hidalgo, A; Fjellstrom, O; Carlsson, L; Badimon, L
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Administration of a soluble ADPase, AZD3366, on top of ticagrelor confers additional cardioprotective benefits to that of ticagrelor alone. (25th November 2020)

Authors:
Vilahur, G; Arzanauskaite, M; Sutelman, P; Ben-Aicha, S; Gutierrez, M; Casani, L; Fjellstrom, O; Carlsson, L; Hidalgo, A; Badimon, L
Journal:
European heart journal
Issue:
Volume 41:(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗